Romatolojik Hastalıklarda JAK İnhibitörlerinin Güvenlilik Profili
Nature Reviews Rheumatology 2017;13:234–43
This review discusses the current understanding of the safety of JAK inhibitors, including providing an overview of the changes in laboratory parameters, infection and malignancy risks associated with each JAK inhibitor compound.The review discusses the adverse event profiles and cellular changes characteristically seen with each JAK inhibitor, as well as the overlap or differences between the various compounds. The relative specificities for different JAKs between each compound do not always p...